These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7978721)

  • 1. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization.
    Mullooly JP; Bennett MD; Hornbrook MC; Barker WH; Williams WW; Patriarca PA; Rhodes PH
    Ann Intern Med; 1994 Dec; 121(12):947-52. PubMed ID: 7978721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
    Nichol KL; Margolis KL; Wuorenma J; Von Sternberg T
    N Engl J Med; 1994 Sep; 331(12):778-84. PubMed ID: 8065407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years.
    Nichol KL; Goodman M
    Vaccine; 2002 May; 20 Suppl 2():S21-4. PubMed ID: 12110251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths.
    Barker WH; Mullooly JP
    JAMA; 1980 Dec; 244(22):2547-9. PubMed ID: 7431593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease.
    Nichol KL; Baken L; Wuorenma J; Nelson A
    Arch Intern Med; 1999 Nov; 159(20):2437-42. PubMed ID: 10665892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of influenza vaccine in the elderly.
    Nichol KL; Margolis KL; Wouremna J; von Sternberg T
    Gerontology; 1996; 42(5):274-9. PubMed ID: 8940650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans.
    Nordin J; Mullooly J; Poblete S; Strikas R; Petrucci R; Wei F; Rush B; Safirstein B; Wheeler D; Nichol KL
    J Infect Dis; 2001 Sep; 184(6):665-70. PubMed ID: 11517426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease.
    Nichol KL; Baken L; Nelson A
    Ann Intern Med; 1999 Mar; 130(5):397-403. PubMed ID: 10068413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.
    Carias C; Reed C; Kim IK; Foppa IM; Biggerstaff M; Meltzer MI; Finelli L; Swerdlow DL
    PLoS One; 2015; 10(7):e0132922. PubMed ID: 26230271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years.
    Nichol KL; Goodman M
    Pharmacoeconomics; 1999; 16 Suppl 1():63-71. PubMed ID: 10623378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influenza vaccination in the elderly population in Mexico: economic considerations].
    Gutiérrez JP; Bertozzi SM
    Salud Publica Mex; 2005; 47(3):234-9. PubMed ID: 16104466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of influenza vaccination in elderly Australians: an exploratory analysis of the vaccine efficacy required.
    Newall AT; Dehollain JP
    Vaccine; 2014 Mar; 32(12):1323-5. PubMed ID: 24486359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.
    Gross PA; Hermogenes AW; Sacks HS; Lau J; Levandowski RA
    Ann Intern Med; 1995 Oct; 123(7):518-27. PubMed ID: 7661497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2010 Jul; 29(169):37-40. PubMed ID: 20712246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rate.
    Merkel PA; Caputo GC
    J Gen Intern Med; 1994 Dec; 9(12):679-83. PubMed ID: 7876950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons.
    Nichol KL; Nordin J; Mullooly J
    Vaccine; 2006 Mar; 24(10):1562-8. PubMed ID: 16300868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could a federal program to promote influenza vaccination among elders be cost-effective?
    Patel MS; Davis MM
    Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community.
    Praditsuwan R; Assantachai P; Wasi C; Puthavatana P; Kositanont U
    J Med Assoc Thai; 2005 Feb; 88(2):256-64. PubMed ID: 15962680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccination.
    Riddiough MA; Sisk JE; Bell JC
    JAMA; 1983 Jun; 249(23):3189-95. PubMed ID: 6406691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.